Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2002
10/10/2002WO2002046178A3 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147352 Process for producing ascorbic acid
10/10/2002US20020147291 Lactone ring-containing (meth)acrylate and polymer thereof for photoresist composition
10/10/2002US20020147234 Nitrate esters and methods of making same
10/10/2002US20020147223 Agent for enhancing accumulation of drugs in tumor tissues
10/10/2002DE10116768A1 Hypoglycemic medicaments useful for treating type II diabetes contain new or known N-aroyl-N'-phenyl-urea derivatives which are glycogen phosphorylase a inhibitors
10/10/2002DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002CA2442365A1 Premixed amiodarone parenteral solution and method for making the same
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002CA2442265A1 Benzofuran derivatives
10/10/2002CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002EP1246820A1 Novel heteroaryl derivatives, their preparation and use
10/09/2002EP1246813A1 Method for the preparation of citalopram
10/09/2002EP1246812A1 Method for the preparation of citalopram
10/09/2002EP1246811A1 Methods for resolving racemic mixtures of 5-substituted 4-hydroxy-2-furanones
10/09/2002EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246696A2 Oxidative reactions using membranes that selectively conduct oxygen
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002EP1105373B1 Unsaturated oxime derivatives and the use thereof as latent acids
10/09/2002EP1100954B1 Continuous process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives
10/09/2002EP1100953B1 CONTINUOUS PROCESS FOR PREPARING OPTICALLY PURE ($i(S))-3-HYDROXY-GAMA-BUTYROLACTONE
10/09/2002EP1100952B1 Process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives
10/09/2002EP1100951B1 PROCESS FOR PREPARING OPTICALLY PURE ($i(S))-3-HYDROXY-GAMA-BUTYROLACTONE
10/09/2002EP0975622B1 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
10/09/2002CN1373754A Antibacterial agents
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002CN1373660A Method for treating chronic pain using MEK inhibitors
10/09/2002CN1373127A Crystal choline ascorbate
10/09/2002CN1092181C Benzyloxy substd, aromatics and their use as fungicides and insecticides
10/09/2002CN1092081C Process for producing coated catalyst for synthesis of maleic anhydride by gas-phase oxidation
10/09/2002CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6462207 Which upon further chemical modification are useful in biomedical applications, permit the synthesis of new polymers, may be used as intermediates in the preparation of compositions possessing properties of interest
10/08/2002US6462205 Method of preparing benzofurandione oxime derivatives
10/08/2002US6462191 Synthesis of 2-deoxy-2-fluoro-arabinose derivatives
10/08/2002US6462158 Useful as base polymers for resist materials for an exposure light source of a short wavelength
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6462077 Thromboxane ligands without blood clotting side effects
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6462075 Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states
10/08/2002US6462074 Substituted α, β-anellated butyrolactones
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002US6462064 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
10/08/2002US6462055 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
10/08/2002US6462053 Neuropeptide y receptor antagonists; cardiovascular and central nervous system disorders and metabolic diseases; hypertension, nephropathy, heart disease, vasospasm, arteriosclerosis
10/08/2002US6462043 Method for producing substituted-2-nitroguanidine derivatives
10/08/2002US6462023 Cytostatic agents
10/08/2002US6461788 Polymerizable compounds having cyclohexanelactone structure and polymers
10/08/2002CA2250066C Process for alkylating and smiles rearrangement of hydroxy aromatics
10/08/2002CA2216245C Preparation of cis-4-o-protected-2-cyclopentenol derivatives
10/08/2002CA2099530C Preparation of form 1 ranitidine hydrochloride
10/03/2002WO2002076969A1 Synthesis of fluorinated molecules possessing high optical non-linearity
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof
10/03/2002WO2002076941A2 Histone deacetylase inhibitors
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076923A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
10/03/2002WO2002058631A3 Primary intermediates for oxidative coloration of hair
10/03/2002WO2002057248A3 Inhibitors of cruzipain and other cysteine proteases
10/03/2002US20020143196 Histone deacetylase inhibitors
10/03/2002US20020143195 Process for the preparation of a-methylenelactones and a-substituted hydrocarbylidene lactones
10/03/2002US20020143192 Oxidizing pseudocumene in presence of a solvent and a catalyst comprising multivalent metals to produce trimellitic acid; crystallizing and filtering; dehydrating to produce trimeillitic anhydride; distillation
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002US20020143054 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
10/03/2002US20020143052 Histone deacetylase inhibitors
10/03/2002US20020143037 For therapy of cancer, hematological disorders, e.g., hemoglobinopathies, and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy.
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142000 Genetic engineering
10/03/2002CA2443289A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002EP1245570A1 Process for the production of (-) 3,4 divanillyl tetrahydrofuran
10/02/2002EP1245553A2 Palladium-catalysed synthesis of aryl ethers
10/02/2002EP1244651A1 Diamidine compounds as dna minor groove binders
10/02/2002EP1244645A1 Stereospecific hydrolysis of optically active esters
10/02/2002EP1152826A4 Phosphorus/vanadium maleic anhydride catalyst preparation
10/02/2002EP1047684B1 Substituted alpha,beta-anellated butyrolactones
10/02/2002EP0906301B1 Benzofuryl derivatives and their use
10/02/2002EP0902784B1 Continuous process for the conversion of 2,5-dihydrofuran to 2,3-dihydrofuran
10/02/2002EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002DE10115408A1 Benzofuran-Derivate Benzofuran derivatives
10/02/2002DE10113587A1 Verfahren zur Herstellung von substituierten Pyrrolen A process for the preparation of substituted pyrroles
10/02/2002DE10111936C1 N-Heteroarylmethyl-m-phenylendiamin-Derivate enthaltende Haarfärbemittel sowie neue N-Heteroarylmethyl-m-phenylendiamin-Derivate N-heteroarylmethyl-m-phenylenediamine derivatives, hair dyes containing as well as new N-heteroarylmethyl-m-phenylenediamine derivatives
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/01/2002US6458982 Transition metal compound, catalyst, its production and its use for the polymerization of olefins
10/01/2002US6458975 Production methods of citalopram and an intermediate therefor
10/01/2002US6458973 Process for the preparation of 5-carboxyphthalide
10/01/2002US6458970 Catalytic gas-phase oxidation of o-xylene or naphthalene or o-xylene/naphthalene mixtures with a gas comprising molecular oxygen over a coated catalyst comprising an inert, nonporous support material on which a catalytically active titanium
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 472